Effects of Neurodevelopmental Therapy on Motor Performance of Infants with Down's Syndrome

Abstract

A group of 20 infants with Down''s syndrome, aged between 2-21 mo., was tested initially on the Bayley Scales of Infant Development and the Peabody Developmental Motor Scales. Four treatment objectives were developed for each individual infant and they were then randomly assigned to an experimental or control group. The experimental group was given an individual neurodevelopmental therapy program 3 times a week in their own homes for a period of 9 wk. When the infants were post-tested on the Bayley and Peabody Scales, no significant difference was found between the 2 groups. There was a statistically significant difference in favor of the experimental group in attainment of individual treatment objectives.